Positive results from moderate-to-severe atopic dermatitis trial
Centessa Pharmaceuticals to be acquired by Lilly
Smart drugs to fight cancer
OpenProtein.AI expands partnership with Boehringer Ingelheim on AI-driven antibody discovery
Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis
InnoCare to move to phase 3 after achieving SLE endpoints
First precision therapy prostate cancer drug approved
FDA approves generalised myasthenia gravis drug
Breast cancer vaccine endpoints met with 74% immune response
Lilly to build $6bn Alabama facility
PsiThera unveiled with $47.5m funding to advance oral medicines
Rapid diagnostic breakthrough against Klebsiella